Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04432272
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:46.263234+00:00
Published At
2021-11-22T00:00:00+00:00
Record Updated At
2022-03-09
Results Posted At
2021-11-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["COVID-19", "Severe Acute Respiratory Syndrome (SARS)", "Coronavirus Infections"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-09"
protocolSection.identificationModule.nctId
"NCT04432272"
protocolSection.identificationModule.officialTitle
"ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-11-22"

Study condition terms

  • COVID-19 (protocolSection.conditionsModule.conditions)
  • Severe Acute Respiratory Syndrome (SARS) (protocolSection.conditionsModule.conditions)
  • Coronavirus Infections (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.